Corbus Pharmaceuticals Holdings (CRBP) Capital Expenditures Growth (1y) (2015 - 2021)
Corbus Pharmaceuticals Holdings (CRBP) Capital Expenditures Growth (1y) (2015 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 112.73 Mn | 84.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 204.00% |
| Dec 31, 2020 | -104.03% |
| Sep 30, 2020 | -95.24% |
| Jun 30, 2020 | -91.37% |
| Mar 31, 2020 | 567.45% |
| Dec 31, 2019 | 163.01% |
| Sep 30, 2019 | 1,028.74% |
| Jun 30, 2019 | -86.96% |
| Mar 31, 2019 | -86.32% |
| Dec 31, 2018 | -498.19% |
| Jun 30, 2018 | 5,672.50% |
| Mar 31, 2018 | 1,165.36% |
| Dec 31, 2017 | 2,459.72% |
| Jun 30, 2017 | -79.57% |
| Mar 31, 2017 | -38.56% |
| Dec 31, 2016 | -78.38% |
| Sep 30, 2016 | -3,696.84% |
| Jun 30, 2016 | 740.49% |
| Mar 31, 2016 | 3,682.40% |
| Sep 30, 2015 | -91.47% |